STOCK TITAN

[Form 4] Evolv Technologies Holdings, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Michael Ellenbogen, Founder & Chief Innovation Officer and Director of Evolv Technologies Holdings, reported significant changes in beneficial ownership on June 23, 2025. The key transaction involved the transfer of investment control of 2,259,987 shares of Class A Common Stock previously held by E Ventures Trust to an independent investment advisor.

Following this transaction, Ellenbogen's holdings include:

  • 2,083,961 shares held directly
  • 151,135 shares held indirectly through Family Horizon Trust

The transfer of investment control means Ellenbogen no longer has beneficial ownership of the E Ventures Trust shares and will not include them in future Section 16 reports. This represents a significant change in his control over company shares while maintaining his executive and board positions.

Michael Ellenbogen, Fondatore, Chief Innovation Officer e Direttore di Evolv Technologies Holdings, ha comunicato il 23 giugno 2025 un cambiamento significativo nella proprietà effettiva. L'operazione principale ha riguardato il trasferimento del controllo sugli investimenti di 2.259.987 azioni di azioni ordinarie di Classe A, precedentemente detenute da E Ventures Trust, a un consulente finanziario indipendente.

Dopo questa operazione, le partecipazioni di Ellenbogen includono:

  • 2.083.961 azioni detenute direttamente
  • 151.135 azioni detenute indirettamente tramite Family Horizon Trust

Il trasferimento del controllo sugli investimenti implica che Ellenbogen non detiene più la proprietà effettiva delle azioni di E Ventures Trust e non le includerà nei futuri rapporti ai sensi della Sezione 16. Ciò rappresenta un cambiamento significativo nel suo controllo sulle azioni della società, pur mantenendo i suoi ruoli esecutivi e nel consiglio di amministrazione.

Michael Ellenbogen, Fundador, Director de Innovación y Director de Evolv Technologies Holdings, informó cambios significativos en la propiedad beneficiaria el 23 de junio de 2025. La transacción clave consistió en la transferencia del control de inversión de 2,259,987 acciones de acciones ordinarias Clase A, anteriormente en poder de E Ventures Trust, a un asesor de inversiones independiente.

Tras esta transacción, las participaciones de Ellenbogen son:

  • 2,083,961 acciones en propiedad directa
  • 151,135 acciones en propiedad indirecta a través de Family Horizon Trust

La transferencia del control de inversión significa que Ellenbogen ya no tiene la propiedad beneficiaria de las acciones de E Ventures Trust y no las incluirá en futuros informes bajo la Sección 16. Esto representa un cambio importante en su control sobre las acciones de la empresa, mientras mantiene sus cargos ejecutivos y en la junta directiva.

마이클 엘렌보겐, Evolv Technologies Holdings의 창립자 겸 최고 혁신 책임자 및 이사,는 2025년 6월 23일에 실질 소유권에 중대한 변동이 있었음을 보고했습니다. 주요 거래는 이전에 E Ventures Trust가 보유하던 2,259,987주의 클래스 A 보통주에 대한 투자 통제권이 독립 투자 자문사로 이전된 것입니다.

이 거래 이후 엘렌보겐의 보유 주식은 다음과 같습니다:

  • 2,083,961주 직접 보유
  • 151,135주 Family Horizon Trust를 통해 간접 보유

투자 통제권 이전으로 인해 엘렌보겐은 더 이상 E Ventures Trust 주식에 대한 실질 소유권을 갖지 않으며, 앞으로 섹션 16 보고서에 이를 포함하지 않을 것입니다. 이는 회사 주식에 대한 그의 통제권에 중대한 변화를 의미하지만, 그는 여전히 경영진 및 이사회 직책을 유지합니다.

Michael Ellenbogen, Fondateur, Directeur de l'Innovation et Administrateur d'Evolv Technologies Holdings, a déclaré des changements significatifs dans la propriété bénéficiaire le 23 juin 2025. La transaction clé concernait le transfert du contrôle des investissements de 2 259 987 actions d'actions ordinaires de Classe A précédemment détenues par E Ventures Trust à un conseiller en investissement indépendant.

À la suite de cette transaction, les participations d'Ellenbogen comprennent :

  • 2 083 961 actions détenues directement
  • 151 135 actions détenues indirectement via Family Horizon Trust

Le transfert du contrôle des investissements signifie qu'Ellenbogen ne détient plus la propriété bénéficiaire des actions d'E Ventures Trust et ne les inclura pas dans les futurs rapports conformément à la Section 16. Cela représente un changement important dans son contrôle des actions de la société, tout en conservant ses fonctions exécutives et au conseil d'administration.

Michael Ellenbogen, Gründer, Chief Innovation Officer und Direktor von Evolv Technologies Holdings, meldete am 23. Juni 2025 wesentliche Änderungen im wirtschaftlichen Eigentum. Die wichtigste Transaktion betraf die Übertragung der Investitionskontrolle von 2.259.987 Aktien der Klasse A Stammaktien, die zuvor von E Ventures Trust gehalten wurden, an einen unabhängigen Anlageberater.

Nach dieser Transaktion umfasst Ellenbogens Beteiligungen:

  • 2.083.961 Aktien direkt gehalten
  • 151.135 Aktien indirekt über den Family Horizon Trust gehalten

Die Übertragung der Investitionskontrolle bedeutet, dass Ellenbogen keine wirtschaftlichen Eigentumsrechte an den E Ventures Trust Aktien mehr besitzt und diese in zukünftigen Berichten gemäß Abschnitt 16 nicht mehr angeben wird. Dies stellt eine bedeutende Änderung seiner Kontrolle über Unternehmensanteile dar, während er seine Führungs- und Vorstandsfunktionen beibehält.

Positive
  • None.
Negative
  • Founder & Chief Innovation Officer Michael Ellenbogen transferred investment control of 2,259,987 shares (held in E Ventures Trust) to an independent investment advisor, reducing his direct influence over a significant portion of his holdings

Michael Ellenbogen, Fondatore, Chief Innovation Officer e Direttore di Evolv Technologies Holdings, ha comunicato il 23 giugno 2025 un cambiamento significativo nella proprietà effettiva. L'operazione principale ha riguardato il trasferimento del controllo sugli investimenti di 2.259.987 azioni di azioni ordinarie di Classe A, precedentemente detenute da E Ventures Trust, a un consulente finanziario indipendente.

Dopo questa operazione, le partecipazioni di Ellenbogen includono:

  • 2.083.961 azioni detenute direttamente
  • 151.135 azioni detenute indirettamente tramite Family Horizon Trust

Il trasferimento del controllo sugli investimenti implica che Ellenbogen non detiene più la proprietà effettiva delle azioni di E Ventures Trust e non le includerà nei futuri rapporti ai sensi della Sezione 16. Ciò rappresenta un cambiamento significativo nel suo controllo sulle azioni della società, pur mantenendo i suoi ruoli esecutivi e nel consiglio di amministrazione.

Michael Ellenbogen, Fundador, Director de Innovación y Director de Evolv Technologies Holdings, informó cambios significativos en la propiedad beneficiaria el 23 de junio de 2025. La transacción clave consistió en la transferencia del control de inversión de 2,259,987 acciones de acciones ordinarias Clase A, anteriormente en poder de E Ventures Trust, a un asesor de inversiones independiente.

Tras esta transacción, las participaciones de Ellenbogen son:

  • 2,083,961 acciones en propiedad directa
  • 151,135 acciones en propiedad indirecta a través de Family Horizon Trust

La transferencia del control de inversión significa que Ellenbogen ya no tiene la propiedad beneficiaria de las acciones de E Ventures Trust y no las incluirá en futuros informes bajo la Sección 16. Esto representa un cambio importante en su control sobre las acciones de la empresa, mientras mantiene sus cargos ejecutivos y en la junta directiva.

마이클 엘렌보겐, Evolv Technologies Holdings의 창립자 겸 최고 혁신 책임자 및 이사,는 2025년 6월 23일에 실질 소유권에 중대한 변동이 있었음을 보고했습니다. 주요 거래는 이전에 E Ventures Trust가 보유하던 2,259,987주의 클래스 A 보통주에 대한 투자 통제권이 독립 투자 자문사로 이전된 것입니다.

이 거래 이후 엘렌보겐의 보유 주식은 다음과 같습니다:

  • 2,083,961주 직접 보유
  • 151,135주 Family Horizon Trust를 통해 간접 보유

투자 통제권 이전으로 인해 엘렌보겐은 더 이상 E Ventures Trust 주식에 대한 실질 소유권을 갖지 않으며, 앞으로 섹션 16 보고서에 이를 포함하지 않을 것입니다. 이는 회사 주식에 대한 그의 통제권에 중대한 변화를 의미하지만, 그는 여전히 경영진 및 이사회 직책을 유지합니다.

Michael Ellenbogen, Fondateur, Directeur de l'Innovation et Administrateur d'Evolv Technologies Holdings, a déclaré des changements significatifs dans la propriété bénéficiaire le 23 juin 2025. La transaction clé concernait le transfert du contrôle des investissements de 2 259 987 actions d'actions ordinaires de Classe A précédemment détenues par E Ventures Trust à un conseiller en investissement indépendant.

À la suite de cette transaction, les participations d'Ellenbogen comprennent :

  • 2 083 961 actions détenues directement
  • 151 135 actions détenues indirectement via Family Horizon Trust

Le transfert du contrôle des investissements signifie qu'Ellenbogen ne détient plus la propriété bénéficiaire des actions d'E Ventures Trust et ne les inclura pas dans les futurs rapports conformément à la Section 16. Cela représente un changement important dans son contrôle des actions de la société, tout en conservant ses fonctions exécutives et au conseil d'administration.

Michael Ellenbogen, Gründer, Chief Innovation Officer und Direktor von Evolv Technologies Holdings, meldete am 23. Juni 2025 wesentliche Änderungen im wirtschaftlichen Eigentum. Die wichtigste Transaktion betraf die Übertragung der Investitionskontrolle von 2.259.987 Aktien der Klasse A Stammaktien, die zuvor von E Ventures Trust gehalten wurden, an einen unabhängigen Anlageberater.

Nach dieser Transaktion umfasst Ellenbogens Beteiligungen:

  • 2.083.961 Aktien direkt gehalten
  • 151.135 Aktien indirekt über den Family Horizon Trust gehalten

Die Übertragung der Investitionskontrolle bedeutet, dass Ellenbogen keine wirtschaftlichen Eigentumsrechte an den E Ventures Trust Aktien mehr besitzt und diese in zukünftigen Berichten gemäß Abschnitt 16 nicht mehr angeben wird. Dies stellt eine bedeutende Änderung seiner Kontrolle über Unternehmensanteile dar, während er seine Führungs- und Vorstandsfunktionen beibehält.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ellenbogen Michael

(Last) (First) (Middle)
C/O EVOLV TECHNOLOGIES, INC.
500 TOTTEN POND ROAD, 4TH FLOOR

(Street)
WALTHAM MA 02451

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Evolv Technologies Holdings, Inc. [ EVLV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Founder & Chief Innovation Ofc
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 06/23/2025 J(1) 2,259,987 D $0 0 I Held by E Ventures Trust
Class A Common Stock 2,083,961 D
Class A Common Stock 151,135 I Held by Family Horizon Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects shares of the Company's common stock held by the E Ventures Trust dated September 12, 2019. The Reporting Person held investment control over all shares held by such trusts until June 23, 2025, on which date investment control over such trust was transferred to an independent investment advisor. As a result, the Reporting Person no longer has beneficial ownership of such shares and the shares will not be included in the Reporting Person's future Section 16 reports.
Remarks:
/s/ Rachel Roy, Attorney-in-fact for Michael Ellenbogen 06/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did EVLV's Michael Ellenbogen report on June 23, 2025?

Michael Ellenbogen, Founder & Chief Innovation Officer of EVLV, reported transferring investment control of 2,259,987 shares of Class A Common Stock held by E Ventures Trust to an independent investment advisor, effectively ending his beneficial ownership of these shares.

How many EVLV shares does Michael Ellenbogen directly own after the June 2025 transaction?

After the reported transaction, Michael Ellenbogen directly owns 2,083,961 shares of EVLV Class A Common Stock.

What positions does Michael Ellenbogen hold at EVLV as of June 2025?

Michael Ellenbogen serves in dual roles at EVLV as both a Director and the Founder & Chief Innovation Officer of the company.

What indirect EVLV stock ownership does Michael Ellenbogen maintain through trusts?

After the transaction, Michael Ellenbogen indirectly owns 151,135 shares through the Family Horizon Trust. He no longer has beneficial ownership of the 2,259,987 shares in E Ventures Trust following the transfer of investment control.
Evolv Technologies Hldngs Inc

NASDAQ:EVLV

EVLV Rankings

EVLV Latest News

EVLV Latest SEC Filings

EVLV Stock Data

939.70M
136.27M
17.09%
56.78%
10.35%
Security & Protection Services
Computer Peripheral Equipment, Nec
Link
United States
WALTHAM